{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:09:29Z","timestamp":1789711769716,"version":"4.0.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Desmodium styracifolium<\/jats:italic>\n                      , known as Guangjinqiancao in Chinese, is a widely used traditional medicinal herb in Southern China for clearing heat and excreting dampness. It has been historically prescribed for the treatment of urological disorders, particularly urolithiasis (Shi Lin). While the clinical efficacy of\n                      <jats:italic>D. styracifolium<\/jats:italic>\n                      is well-documented, the precise mechanisms of its primary active fraction, total flavonoids of\n                      <jats:italic>D. styracifolium<\/jats:italic>\n                      (TFDS), regarding crystallization and inflammation remain to be fully elucidated. This study aims to investigate the therapeutic mechanism of TFDS in alleviating nephrolithiasis by systematically evaluating its effects on calcium oxalate (CaOx) crystallization kinetics, crystal-cell interaction, and renal inflammatory responses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The inhibitory effects of TFDS on calcium oxalate monohydrate (COM) crystallization were quantified\n                      <jats:italic>in vitro<\/jats:italic>\n                      , assessing crystal nucleation and growth. Flow cytometry and microscopy were utilized to evaluate the effect of TFDS on crystal adhesion and endocytosis in renal tubular epithelial cells. RT-qPCR was used to assess the expression of inflammatory cytokines. Furthermore, an ethylene glycol and ammonium chloride-induced rat model of nephrolithiasis was employed to evaluate the anti-lithogenic effect of TFDS\n                      <jats:italic>in vivo<\/jats:italic>\n                      , utilizing ultrasonography, serum\/urine biochemistry, and histopathological analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>In vitro<\/jats:italic>\n                      assays demonstrated that TFDS significantly inhibits COM crystal formation and growth in a dose-dependent manner. Notably, TFDS promoted the dissolution of pre-formed crystals and effectively blocked the adhesion and internalization of crystals by renal cells. Moreover, TFDS treatment suppressed the crystal-induced upregulation of pro-inflammatory cytokines (IL-6, IL-8, TNF-\u03b1).\n                      <jats:italic>In vivo<\/jats:italic>\n                      experiments demonstrated that the administration of TFDS significantly attenuated renal crystal retention, reduced tissue damage, and improved renal function.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      TFDS exerts a potent anti-lithogenic effect by targeting multiple stages of the crystallization process\u2014inhibiting crystal nucleation and growth, promoting dissolution, and preventing cellular adhesion and endocytosis,and suppressing associated inflammation. These findings provide a scientific cognition for the traditional use of\n                      <jats:italic>D. styracifolium<\/jats:italic>\n                      and elucidate the mechanism of action for TFDS-based therapies in managing nephrolithiasis.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1873638","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:38:01Z","timestamp":1789709881000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Total flavonoids of Desmodium styracifolium attenuate nephrolithiasis via reducing calcium oxalate crystallization and renal inflammation"],"prefix":"10.3389","volume":"17","author":[{"given":"Yang","family":"Yang","sequence":"first","affiliation":[{"name":"Hubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd.","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxue","family":"Yang","sequence":"additional","affiliation":[{"name":"Hubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd.","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Hubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd.","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikui","family":"Cheng","sequence":"additional","affiliation":[{"name":"Hubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd.","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuojian","family":"Lu","sequence":"additional","affiliation":[{"name":"Hubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd.","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyong","family":"Lv","sequence":"additional","affiliation":[{"name":"Hubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd.","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"Wei","sequence":"additional","affiliation":[{"name":"Hubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd.","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Hubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd.","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Feng","sequence":"additional","affiliation":[{"name":"Hubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd.","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yue","sequence":"additional","affiliation":[{"name":"Hubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd.","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Du","sequence":"additional","affiliation":[{"name":"Hubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd.","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifei","family":"Liu","sequence":"additional","affiliation":[{"name":"Hubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd.","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd.","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12301-024-00436-z","article-title":"Urolithiasis unveiled: pathophysiology, stone dynamics, types, and inhibitory mechanisms: a review","volume":"30","author":"Allam","year":"2024","journal-title":"Afr. J. Urol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s41581-025-00990-x","article-title":"Kidney stone disease: risk factors, pathophysiology and management","volume":"21","author":"Bargagli","year":"2025","journal-title":"Nat. Rev. Nephrol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5489\/cuaj.8935","article-title":"Trends in kidney stone prevalence among U.S. adults: a concerning contemporary gender analysis from the NHANES database","volume":"19","author":"Chen","year":"2024","journal-title":"CUAJ"},{"key":"B4","doi-asserted-by":"publisher","first-page":"110452","DOI":"10.1016\/j.abb.2025.110452","article-title":"Mitochondrial Enzyme HIBADH protects against calcium oxalate nephrolithiasis by modulating oxidative stress and apoptosis","volume":"770","author":"Chen","year":"2025","journal-title":"Archives Biochem. Biophysics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1021\/acschemneuro.1c00314","article-title":"Schaftoside suppresses pentylenetetrazol-induced seizures in zebrafish via suppressing apoptosis, modulating inflammation, and oxidative stress","volume":"12","author":"Dang","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.nefroe.2025.02.003","article-title":"Unveiling the antiurolithiatic potentiality of two benzene sulfonamide derivatives against ethylene glycol-induced renal calculi","volume":"45","author":"Elgendy","year":"2025","journal-title":"Nefrol. Engl. Ed."},{"key":"B7","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s00467-009-1116-y","article-title":"Physiopathology and etiology of stone formation in the kidney and the urinary tract","volume":"25","author":"Evan","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1272900","DOI":"10.3389\/fmed.2023.1272900","article-title":"In focus: perplexing increase of urinary stone disease in children, adolescent and young adult women and its economic impact","volume":"10","author":"Filler","year":"2023","journal-title":"Front. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1113\/EP085299","article-title":"Principles and standards for reporting animal experiments in the journal of physiology and experimental physiology","volume":"100","author":"Grundy","year":"2015","journal-title":"Exp. Physiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1464-410X.1993.tb15906.x","article-title":"Effect of Desmodium styracifolium\u2010triterpenoid on calcium oxalate renal stones","volume":"71","author":"Hirayama","year":"1993","journal-title":"Br. J. Urology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11547-018-0962-8","article-title":"A rat model of acute kidney injury through systemic hypoperfusion evaluated by micro-US, color and PW-Doppler","volume":"124","author":"Iacobellis","year":"2019","journal-title":"Radiol. Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00240-024-01677-x","article-title":"Prolyl hydroxylase domain inhibitors prevent kidney crystal formation by suppressing inflammation","volume":"53","author":"Kawase","year":"2024","journal-title":"Urolithiasis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"111903","DOI":"10.1016\/j.biopha.2021.111903","article-title":"Dual modulatory effects of diosmin on calcium oxalate kidney stone formation processes: crystallization, growth, aggregation, crystal-cell adhesion, internalization into renal tubular cells, and invasion through extracellular matrix","volume":"141","author":"Khamchun","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1248\/cpb.37.2229","article-title":"Study on the constituents of Desmodium styracifolium","volume":"37","author":"Kubo","year":"1989","journal-title":"Chem. Pharm. Bull."},{"key":"B14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1089\/ars.2019.7791","article-title":"Activation of Farnesoid X receptor by schaftoside ameliorates acetaminophen-induced hepatotoxicity by modulating oxidative stress and inflammation","volume":"33","author":"Liu","year":"2020","journal-title":"Antioxid. Redox Signal"},{"key":"B15","doi-asserted-by":"publisher","first-page":"156483","DOI":"10.1016\/j.cyto.2023.156483","article-title":"Schaftoside reduces inflammation in Aspergillus fumigatus keratitis through the inhibition of the TLR4\/MyD88 pathway","volume":"175","author":"Lu","year":"2024","journal-title":"Cytokine"},{"key":"B16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jep.2011.09.053","article-title":"The genus Desmodium (Fabaceae)-traditional uses in Chinese medicine, phytochemistry and pharmacology","volume":"138","author":"Ma","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00240-011-0401-y","article-title":"Evaluation of antiurolithic effect and the possible mechanisms of Desmodium styracifolium and Pyrrosiae petiolosa in rats","volume":"40","author":"Mi","year":"2012","journal-title":"Urol. Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e25058","DOI":"10.1016\/j.heliyon.2024.e25058","article-title":"Desmodium styracifolium: botanical and ethnopharmacological insights, phytochemical investigations, and prospects in pharmacology and pharmacotherapy","volume":"10","author":"Opryshko","year":"2024","journal-title":"Heliyon"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.3909\/riu0459","article-title":"Kidney stones: a global picture of prevalence, incidence, and associated risk factors","volume":"12","author":"Romero","year":"2010","journal-title":"Rev. Urol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"107743","DOI":"10.1016\/j.vascn.2025.107743","article-title":"A comparative study of kidney lithogenic agents in Wistar rats by invasive and noninvasive methods","volume":"133","author":"Sakthikarthikeyan","year":"2025","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"B21","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"B22","doi-asserted-by":"publisher","first-page":"23211","DOI":"10.1021\/acsomega.1c02840","article-title":"Styracifoline from the Vietnamese plant Desmodium styracifolium: a potential inhibitor of diabetes-related and thrombosis-based proteins","volume":"6","author":"Tran","year":"2021","journal-title":"ACS Omega"},{"key":"B23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.urology.2019.04.012","article-title":"Pediatric urinary stone disease in the United States: the urologic diseases in America project","volume":"129","author":"Ward","year":"2019","journal-title":"Urology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00240-015-0795-z","article-title":"Antilithic effects of extracts from different polarity fractions of Desmodium styracifolium on experimentally induced urolithiasis in rats","volume":"43","author":"Xiang","year":"2015","journal-title":"Urolithiasis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11010-017-3201-z","article-title":"Total flavone of Desmodium styracifolium relieved apoptosis and autophagy of COM-induced HK-2 cells by regulating KIM-1 via p38\/MAPK pathway","volume":"442","author":"Xie","year":"2018","journal-title":"Mol. Cell Biochem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e70180","DOI":"10.1111\/jcmm.70180","article-title":"Puerarin alleviates apoptosis and inflammation in kidney stone cells via the PI3K\/AKT pathway: network pharmacology and experimental verification","volume":"28","author":"Xu","year":"2024","journal-title":"J. Cell. Mol. Medi"},{"key":"B27","doi-asserted-by":"publisher","first-page":"118135","DOI":"10.1016\/j.jep.2024.118135","article-title":"Bioactive compound schaftoside from Clinacanthus nutans attenuates acute liver injury by inhibiting ferroptosis through activation the Nrf2\/GPX4 pathway","volume":"328","author":"Yu","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10863-025-10076-9","article-title":"Total favonoids of Desmodium Styracifolium relieve renal ischemia\u2013reperfusion injury by suppressing ferroptosis through P53\/SLC7A11\/GPX4 signaling pathway: (Running title) TFDS relieved renal ischemia\u2013reperfusion injury","volume":"57","author":"Yuan","year":"2025","journal-title":"J. Bioenerg. Biomembr."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.17219\/acem\/152207","article-title":"Schaftoside improves cerebral ischemia-reperfusion injury by enhancing autophagy and reducing apoptosis and inflammation through the AMPK\/mTOR pathway","volume":"31","author":"Zhang","year":"2022","journal-title":"Adv. Clin. Exp. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.phytochem.2007.02.015","article-title":"Isoflavanones and their O-glycosides from Desmodium styracifolium","volume":"68","author":"Zhao","year":"2007","journal-title":"Phytochemistry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00240-017-0985-y","article-title":"Total flavonoids of Desmodium styracifolium attenuates the formation of hydroxy-l-proline-induced calcium oxalate urolithiasis in rats","volume":"46","author":"Zhou","year":"2018","journal-title":"Urolithiasis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jphs.2018.10.012","article-title":"Schaftoside ameliorates oxygen glucose deprivation-induced inflammation associated with the TLR4\/Myd88\/Drp1-related mitochondrial fission in BV2 microglia cells","volume":"139","author":"Zhou","year":"2019","journal-title":"J. Pharmacol. Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1873638\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:38:02Z","timestamp":1789709882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1873638\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":33,"alternative-id":["10.3389\/fphar.2026.1873638"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1873638","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"article-number":"1873638"}}